Dr. Angelique Coetzee, a Private Practitioner and Chair of the South African Medical Association, joins Worldwide Exchange to discuss the omicron Covid variant, after being one of the first doctors to spot the symptoms. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
Covid symptoms linked to the new omicron variant have been described as “extremely mild” by the South African doctor who first raised the alarm over the new strain.
Dr. Angelique Coetzee, chair of the South African Medical Association, told the BBC on Sunday that she started to see patients around Nov.18 presenting with “unusual symptoms” that differed slightly from those associated with the delta variant, which is the most virulent strain of the virus to date and globally dominant.
“It actually started with a male patient who’s around the age of 33 … and he said to me that he’s just [been] extremely tired for the past few days and he’s got these body aches and pains with a bit of a headache,” she told the BBC.
The patient didn’t have a sore throat, she said, but more of a “scratchy throat” but no cough or loss of taste or smell — symptoms that have been associated with previous strains of the coronavirus.
Coetzee said she tested the male patient for Covid, and he was positive, as was his family, and then said she saw more patients that day presenting with the same kinds of symptoms that differed from the delta variant.
This prompted her to raise the alarm with South Africa’s vaccine advisory committee, of which she is a member.
Other patients Coetzee had seen so far with the omicron variant had also experienced what she described as “extremely mild” symptoms, and she added that her colleagues had noted similar cases.
“What we are seeing clinically in South Africa — and remember I’m at the epicenter of this where I’m practicing — is extremely mild, for us [these are] mild cases. We haven’t admitted anyone, I’ve spoken to other colleagues of mine and they give the same picture.”
The WHO has said it will take weeks to understand how the variant may affect diagnostics, therapeutics and vaccines.
Coetzee’s initial observations are only based on a very small number of cases and experts are worried about omicron’s large number of mutations. Preliminary evidence suggests the strain has an increased risk of reinfection, according to the WHO.
Early data suggests that the variant is spreading in South Africa more rapidly than previous strains did and that the variant, known formally as B.1.1.529, could be starting to trigger a new wave of infections, according to analysis by the Financial Times.
It could take a while to fully understand what specific symptoms, if any, are attributable to the new omicron variant on a wider scale.
Covid symptoms have changed since the virus first emerged in China in late 2019. The “alpha” and “delta” variants, first discovered in the U.K. and India, respectively, were seen to cause different symptoms, for example, with the latter causing more headaches, sore throat, runny nose and fever.
The U.S. CDC has highlighted the variety of Covid symptoms that have been reported, noting “anyone can have mild to severe symptoms” that may appear two to 14 days after exposure to the virus.
On the list of symptoms from the CDC are fever or chills, a cough, fatigue, shortness of breath or difficulty breathing, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or a runny nose, nausea or vomiting and diarrhea.
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC